Author

Martin McLaughlin

Institute of Cancer ResearchORCID 0000-0002-9739-7133Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Martin McLaughlin3 papers · Institute of Cancer Research

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Assay:imaging· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Alan A. MelcheriD· 1 shared Amy BurleyiD· 1 shared Anton PatrikeeviD· 1 shared Antonio RullaniD· 1 shared Charleen Chan Wah HakiD· 1 shared Eleanor Clancy‐Thompson· 1 shared Emmanuel Christian PatiniD· 1 shared Heba Soliman· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Alan A. MelcherORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

ImmunologyNature CommunicationsPeer-reviewedAug 12, 2024

Sculpting the tumour microenvironment by combining radiotherapy and ATR inhibition for curative-intent anti-PD-L1- and anti-NKG2A-based adjuvant immunotherapy

Emmanuel Christian Patin, Pablo Nenclares, Charleen Chan Wah Hak…·Kevin Joseph Harrington

This study combines ATR inhibition with radiotherapy and immune checkpoint blockade to enhance antitumour immunity in HNSCC preclinical models.

22 citations

mouseproteomics

𝕏 PostBluesky